Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate
2010 ◽
Vol 55
(10)
◽
pp. A53.E501
2017 ◽
Vol 135
(25)
◽
pp. 2494-2504
◽
2017 ◽
Vol 11
(4)
◽
pp. 1023-1031
◽
2011 ◽
Vol 75
(1)
◽
pp. 76-82
◽
2016 ◽
Vol 36
(suppl_1)
◽
2016 ◽
Vol 10
(3)
◽
pp. 610-618
◽